Keros Therapeutics Inc (KROS)
16.49
-0.22
(-1.32%)
USD |
NASDAQ |
Dec 26, 11:48
Keros Therapeutics Cash from Investing (Quarterly): -0.386M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aptevo Therapeutics Inc | 0.00 |
| Corcept Therapeutics Inc | -44.04M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Scholar Rock Holding Corp | 35.31M |
| Trevi Therapeutics Inc | 7.667M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.50M |
| Cash from Financing (Quarterly) | 155.94M |
| Free Cash Flow | -142.50M |
| Free Cash Flow Per Share (Quarterly) | -0.8216 |
| Free Cash Flow to Equity (Quarterly) | -30.89M |
| Free Cash Flow Yield | -24.78% |